Evaluation of early clinical failure criteria for gram-negative bloodstream infections

被引:25
作者
Rac, H. [1 ]
Gould, A. P. [2 ]
Bookstaver, P. B. [1 ,3 ]
Justo, J. A. [1 ,3 ]
Kohn, J. [3 ]
Al-Hasan, M. N. [4 ,5 ]
机构
[1] Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA
[2] Novant Hlth, Charlotte, NC USA
[3] Prisma Hlth Richland, Columbia, SC USA
[4] Univ South Carolina, Sch Med, Columbia, SC 29208 USA
[5] Palmetto Hlth Univ, South Carolina Med Grp, Columbia, SC USA
关键词
Antibiotics; Bacteraemia; Bloodstream infection; Clinical failure; Early clinical failure; Enterobacteriaceae; Gram-negative infection; Treatment response; EMPIRICAL ANTIMICROBIAL THERAPY; ENTEROBACTERIACEAE BACTEREMIA; NOSOCOMIAL INFECTIONS; BETA-LACTAMS; SCORE; ADULTS; DURATION; RISK; STRATIFICATION; CEPHALOSPORINS;
D O I
10.1016/j.cmi.2019.05.017
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim was the development of early clinical failure criteria (ECFC) to predict unfavourable outcomes in patients with Gram-negative bloodstream infections (GN-BSI). Methods: Adults with community-onset GN-BSI who survived hospitalization for >= 72 hr at Prisma Health-Midlands hospitals in Columbia, SC, USA from January 1, 2010 to June 30, 2015 were identified. Multivariable logistic regression was used to examine the association between clinical variables between 72 and 96 hr after GN-BSI and unfavourable outcomes (28-day mortality or hospital length of stay >14 days from GN-BSI onset). Results: Among 766 patients, 225 (29%) had unfavourable outcomes. After adjustments for Charlson Comorbidity Index and appropriateness of empirical antimicrobial therapy in multivariable model, predictors of unfavourable outcomes included systolic blood pressure <100 mmHg or vasopressor use (adjusted odds ratio (aOR) 1.8, 95% confidence interval (CI) 1.2-2.9), heart rate >100 beats/minute (aOR 1.7, 95% CI 1.1-2.5), respiratory rate >= 22 breaths/minute or mechanical ventilation (aOR 2.1, 95% CI 1.4-3.3), altered mental status (aOR 4.5, 95% CI 2.8-7.1), and white blood cell count >12 000/mm(3) (aOR 2.7, 95% CI 1.8-4.1) between 72 and 96 hr after index GN-BSI. Area under receiver operating characteristic curve of ECFC model in predicting unfavourable outcomes was 0.77 (0.84 and 0.71 in predicting 28-day mortality and prolonged hospitalization, respectively). Conclusions: Risk of 28-day mortality or prolonged hospitalization can be estimated between 72 and 96 hr after GN-BSI using ECFC. These criteria may have clinical utility in management of GN-BSI and may improve methodology of future investigations assessing response to antimicrobial therapy based on a standard evidence-based definition of early clinical failure. (c) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [21] Bloodstream infections in pediatric patients with acute leukemia: Emphasis on gram-negative bacteria infections
    Kuo, Fu-Chun
    Wang, Shih-Min
    Shen, Ching-Fen
    Ma, Yun-Ju
    Ho, Tzong-Shiann
    Chen, Jiann-Shiuh
    Cheng, Chao-Neng
    Liu, Ching-Chuan
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2017, 50 (04) : 507 - 513
  • [22] An identification protocol for ESBL-producing Gram-negative bacteria bloodstream infections using a MinION nanopore sequencer
    Sakai, Jun
    Tarumoto, Norihito
    Kodana, Masahiro
    Ashikawa, Sae
    Imai, Kazuo
    Kawamura, Toru
    Ikebuchi, Kenji
    Murakami, Takashi
    Mitsutake, Kotaro
    Maeda, Takuya
    Maesaki, Shigefumi
    JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (08) : 1219 - 1226
  • [23] Predictive Factors for Gram-negative Versus Gram-positive Bloodstream Infections in Children With Cancer
    Sfetsiori, Angeliki-Eleni
    Doganis, Dimitrios
    Doudoulakakis, Anastasios
    Spyridis, Nikolaos
    Pourtsidis, Apostolos
    Servitzoglou, Marina
    Nikita, Maria
    Papachristidou, Smaragda
    Magkou, Evgenia
    Dana, Helen
    Lebessi, Evangelia
    Kosmidis, Helen
    Baka, Margarita
    Tsolia, Maria
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022, 44 (02) : E368 - E373
  • [24] Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features
    Leal, Helena Ferreira
    Azevedo, Jailton
    Oliveira Silva, Giulyana Evelyn
    Lima Amorim, Angelica Maria
    Cabral de Roma, Larissa Rangel
    Palmeira Arraes, Ana Carolina
    Gouveia, Edilane Lins
    Reis, Mitermayer Galvao
    Mendes, Ana Verena
    Silva, Marcio de Oliveira
    Barberino, Maria Goreth
    Martins, Ianick Souto
    Reis, Joice Neves
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [25] Minimum Acceptable Susceptibility of Empirical Antibiotic Regimens for Gram-Negative Bloodstream Infections: A Survey of Clinical Pharmacists
    Haggard, Emily
    Hagedorn, Maureen
    Bookstaver, P. Brandon
    Justo, Julie Ann
    Kohn, Joseph
    Al-Hasan, Majdi N.
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2018, 26 (05) : 283 - 287
  • [26] Variability in oral antibiotic step-down therapy in the management of Gram-negative bloodstream infections
    Thaden, Joshua T.
    Tamma, Pranita D.
    Doi, Yohei
    Daneman, Nick
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 (06)
  • [27] Oral antibiotics for the treatment of Gram-negative bloodstream infections: A retrospective comparison of three antibiotic classes
    Nisly, Sarah A.
    McClain, Dominique L.
    Fillius, Amy G.
    Davis, Kyle A.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 20 : 74 - 77
  • [28] Treatment of multidrug-resistant Gram-negative bloodstream infections in critically ill patients: an update
    Viasus, Diego
    Gudiol, Carlota
    Carratala, Jordi
    CURRENT OPINION IN CRITICAL CARE, 2024, 30 (05) : 448 - 455
  • [29] Gram-negative bloodstream infections and sepsis: risk factors, screening tools and surveillance
    Mitchell, Eleanor
    Pearce, Mark S.
    Roberts, Anthony
    BRITISH MEDICAL BULLETIN, 2019, 132 (01) : 5 - 15
  • [30] Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation
    Da Prat, Valentina
    Galli, Laura
    Cichero, Paola
    Castiglioni, Barbara
    Oltolini, Chiara
    Tassan Din, Chiara
    Andolina, Andrea
    Bruzzesi, Elena
    Poli, Andrea
    Moro, Matteo
    Mancini, Nicasio
    Clementi, Massimo
    Tresoldi, Moreno
    Castagna, Antonella
    Scarpellini, Paolo
    Ripa, Marco
    INFECTIOUS DISEASES, 2023, 55 (04) : 255 - 262